Larvol Delta - Pharmacokinetics-and-Tolerability-of-Subcutaneous-Dupilumab-Coformulated-With-Berahyaluronidase-Alfa-and-Dupilumab-Without-Berahyaluronidase-Alfa-in-Healthy-Participants

berahyaluronidase alfa (ALT-B4) - Biogen

Dupixent (dupilumab) - Sanofi, Regeneron

http://clinicaltrials.gov/ct2/show/NCT07646548

Jun 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next